References
- von Buchwald C, Bradley PJ. Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg. 2007;15:95–98.
- Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer. 2001;37 Suppl 4:S9–S15.
- Linggi B, Carpenter G. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol. 2006;16:649–656.
- Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses. Ann Otol Rhinol Laryngol. 1971;80:192–206.
- Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem. 1990;265:7709–7712.
- Jacobi N, Seeboeck R, Hofmann E, et al. ErbB family signalling: a paradigm for oncogene addiction and personalized oncology. Cancers. 2017;9:33.
- Hirsch FR, Varella-Garcia M, Bunn PJ, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. JCO. 2003;21:3798–3807.
- Katori H, Nozawa A, Fau Tsukuda M, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol. 2005;31:905–911.
- Barnes L, Eveson JW, Reichart P, et al. World health organization classification of tumors: pathology and genetics: head and neck tumors. Lyon: IARC Press; 2005.
- Krouse JH. Development of a staging system for inverted papilloma. Laryngoscope. 2000;110:965–968.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
- Jia JB, Wang WQ, Sun HC, et al. High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection. Oncologist. 2010;15:732–743.
- Oda K, Matsuoka Y, Funahashi A, et al. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol. 2005;1:E1–2010.
- Downward J, Parker P, Waterfield MD. Autophosphorylation sites on the epidermal growth factor receptor. Nature. 1984;311:483–485.
- Kumagai K, Horikawa T, Gotoh A, et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:748–754.
- Olayioye MA. Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res. 2001;3:385–389.
- Appert-Collin A, Hubert P, Cremel G, et al. Role of ErbB receptors in cancer cell migration and invasion. Front Pharmacol. 2015;6:283–290.
- Tan M, Yu D. Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. Adv Exp Med Biol. 2007;608:119–129.
- Boonstra J, De Laat SW, Ponec M. Epidermal growth factor receptor expression related to differentiation capacity in normal and transformed keratinocytes. Exp Cell Res. 1985;161:421–433.
- Stoscheck CM, King LJ. Role of epidermal growth factor in carcinogenesis. Cancer Res. 1986;46:1030–1037.